CHANGE THE CONTENT OF THE APO B WITH THE DEVELOPMENT OF EXPERIMENTAL HYPERCHOLESTEROLEMIA AND WAYS TO CORRECT IT

Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/1294

Title:	CHANGE THE CONTENT OF THE APO B WITH THE DEVELOPMENT OF EXPERIMENTAL HYPERCHOLESTEROLEMIA AND WAYS TO CORRECT IT
Authors:	Azizova, Dilzoda Sabirova, Rikhsi Khalilova, R
Keywords:	experimental hypercholesterolemia, blood, atherosclerosis, lipoproteins, cholesterol, apoprotein B.
Issue Date:	May-2019
Publisher:	WORLD JOURNAL OF PHARMACEUTICAL AND MEDICAL RESEARCH
Abstract:	The study examined the effect of Biomaysa on the content of apoprotein in and total cholesterol, lipoprotein cholesterol in the dynamics of experimental hypercholesterolemia. Apoprotein B. of combined administration Biomaysa and ultroksa installed significant difference in the reduction of total cholesterol levels in ApoB 2.2 and 1.5, indicating good cholesterol reducing the effectiveness of the combination of these drugs by activating LDL receptor capture.
URI:	http://repository.tma.uz/xmlui/handle/1/1294
ISSN:	2455-3301 WJPMR
Appears in Collections:	Thesis, Articles

Files in This Item:

File	Description	Size	Format
1.pdf		398.2 kB	Adobe PDF	View/Open

DSpace JSPUI